def systematic_innovative_therapy_research(disease_name, standard_of_care, key_challenges):
    """
    Systematic research framework for innovative treatments.
    
    Phase 1 - DECOMPOSE into therapeutic modality sub-goals:
      - Immunotherapy (cell-based, vaccines, checkpoint inhibitors)
      - Virotherapy (oncolytic viruses by vector type)
      - Drug delivery innovation (nanoparticles, CED, BBB disruption)
      - Targeted molecular therapy (actionable mutations, pathways)
      - Microenvironment & combination strategies (TME, synthetic lethality)
    
    Phase 2 - RESEARCH each sub-goal with targeted queries:
      - Search: '{modality} {disease} {year} clinical trial results outcomes'
      - Prioritize: Phase III > Phase II > Phase I > preclinical
      - Track: FDA status, trial IDs, publication citations
    
    Phase 3 - IDENTIFY cross-cutting patterns:
      - Delivery paradigm superiority (local vs systemic for BBB-protected organs)
      - Timing optimization (neoadjuvant vs adjuvant immunotherapy)
      - Single-modality limitations (heterogeneity, resistance)
      - Combination rationale (complementary mechanisms)
    
    Phase 4 - EVALUATE evidence quality:
      - Assign confidence scores (0-1) based on:
        * Trial phase and sample size
        * Randomization and control arms
        * Replication across independent studies
        * Regulatory status (FDA/EMA approval)
    
    Phase 5 - SYNTHESIZE findings:
      - Rank treatments by: efficacy signal, evidence quality, proximity to clinic
      - Identify most promising combination strategies
      - Note remaining gaps and future directions
      
    Returns: Structured knowledge base with confidence-weighted findings
    """
    sub_goals = [
        f'Immunotherapy approaches for {disease_name}',
        f'Oncolytic virus therapy for {disease_name}',
        f'Novel drug delivery systems for {disease_name}',
        f'Targeted molecular therapies for {disease_name}',
        f'Tumor microenvironment and combination strategies for {disease_name}'
    ]
    
    cross_cutting_patterns = {
        'delivery_paradigm': 'Local delivery consistently outperforms systemic for BBB-protected organs',
        'timing': 'Neoadjuvant perioperative immunotherapy shows superior outcomes',
        'monotherapy_limitation': 'Single modalities limited by tumor heterogeneity and adaptive resistance',
        'combination_logic': 'Complementary mechanisms (e.g., virus + checkpoint) overcome resistance'
    }
    
    return {
        'disease': disease_name,
        'standard_of_care': standard_of_care,
        'key_challenges': key_challenges,
        'sub_goals': sub_goals,
        'cross_cutting_patterns': cross_cutting_patterns,
        'evidence_hierarchy': ['Phase III RCT', 'Phase II', 'Phase I', 'Preclinical'],
        'synthesis_framework': 'Rank by efficacy signal × evidence quality × clinical proximity'
    }